Total planned funding: $167,851,843
Allocations
Countries/Regions
India | $167,851,843 |
Organizational Types
Unknown | $63,520,750 |
NGO | $50,891,890 |
Own Agency | $25,333,214 |
University | $15,790,217 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,460,000 |
Host Country Government Agency | $1,609,200 |
FBO | $1,400,000 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $69,598,038 |
Prevention | $40,132,587 |
Care | $23,625,376 |
Management and Operations | $19,409,425 |
Testing | $7,758,753 |
Treatment | $7,327,664 |
Budget Codes
OHSS: Health Systems Strengthening | $41,235,313 |
HVSI: Strategic Information | $22,955,076 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,528,530 |
HVMS: Management and Operations | $19,409,425 |
HBHC: Care: Adult Care and Support | $14,784,956 |
HVCT: Testing: HIV Testing and Counseling | $7,758,753 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,420,551 |
HTXS: Treatment: Adult Treatment | $6,836,029 |
HLAB: Laboratory Infrastructure | $5,407,649 |
HKID: Care: Orphans and Vulnerable Children | $4,888,033 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,298,507 |
HVTB: Care: TB/HIV | $3,420,337 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,111,320 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
PDCS: Care: Pediatric Care and Support | $532,050 |
PDTX: Treatment: Pediatric Treatment | $468,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$62,473,261
Countries/Regions
USG Aggregated Agencies:
$13,386,784
Countries/Regions
Voluntary Health Services:
$11,840,000
Countries/Regions
FHI 360:
$10,951,525
Countries/Regions